These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16113829)

  • 1. Long-term prognostic value of protein C activity, erythrocyte aggregation and membrane fluidity in transmural myocardial infarction.
    Sargento L; Saldanha C; Monteiro J; Perdigão C; e Silva JM
    Thromb Haemost; 2005 Aug; 94(2):380-8. PubMed ID: 16113829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic value of the hemorheological profile in transmural myocardial infarction survivors: 60-month clinical follow-up.
    Sargento L; Do Rosário HS; Perdigão C; Monteiro J; Saldanha C; Martins e Silva J
    Rev Port Cardiol; 2002 Nov; 21(11):1263-75. PubMed ID: 12564079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of prolonged disturbances in the haemostatic, hemorheologic and inflammatory profiles in transmural myocardial infarction survivors.
    Sargento L; Saldanha C; Monteiro J; Perdigão C; Martins e Silva J
    Thromb Haemost; 2003 May; 89(5):892-903. PubMed ID: 12719788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biohemorheologic factors and cardiovascular events curve in survivors of transmural acute myocardial infarct--24-month follow-up].
    Sargento L; do Rosário HS; Perdigão C; Monteiro J; Saldanha C; e Silva JM
    Rev Port Cardiol; 2002 Feb; 21(2):165-71. PubMed ID: 11963286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of the erythrocyte membrane fluidity in survivors of acute myocardial infarction. A prospective study.
    Saldanha C; Sargento L; Monteiro J; Perdigão C; Ribeiro C; Martins-Silva J
    Clin Hemorheol Microcirc; 1999; 20(2):111-6. PubMed ID: 10416813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte aggregation portends worse outcomes in unstable angina patients undergoing percutaneous coronary interventions.
    Steinvil A; Arbel Y; Leshem-Rubinow E; Halkin A; Keren G; Revivo M; Finkelstein A; Cohen M; Tal R; Aviram G; Berliner S; Banai S
    Clin Hemorheol Microcirc; 2013 Jan; 55(2):213-21. PubMed ID: 23144163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of ten-year event-free survival in patients with acute myocardial infarction (from the Adria, Bassano, Conegliano, and Padova Hospitals [ABC] study on myocardial infarction).
    Berton G; Cordiano R; Cavuto F; Giacomini G; De Toni R; Palatini P
    Am J Cardiol; 2012 Apr; 109(7):966-75. PubMed ID: 22221943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].
    Díaz CJ; Núñez AC; Flores MI; Arcaute HD; Archondo T
    Arch Cardiol Mex; 2006; 76(4):366-75. PubMed ID: 17315612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low normal level of protein C or of antithrombin increases risk for recurrent cardiovascular events.
    Pelkonen KM; Wartiovaara-Kautto U; Nieminen MS; Ahonen K; Sinisalo J
    Blood Coagul Fibrinolysis; 2005 Jun; 16(4):275-80. PubMed ID: 15870547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute-phase reactants in acute myocardial infarction: impact on 5-year prognosis.
    Mariotti R; Musumeci G; De Carlo M; Biadi O; Caravelli P; Limbruno U; Mariani M
    Ital Heart J; 2001 Apr; 2(4):294-300. PubMed ID: 11374499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up.
    Gul M; Uyarel H; Ergelen M; Karacimen D; Ugur M; Turer A; Bozbay M; Ayhan E; Akgul O; Uslu N
    Coron Artery Dis; 2012 Aug; 23(5):330-6. PubMed ID: 22735091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil to lymphocyte ratio predicts short- and long-term mortality following revascularization therapy for ST elevation myocardial infarction.
    Sawant AC; Adhikari P; Narra SR; Srivatsa SS; Mills PK; Srivatsa SS
    Cardiol J; 2014; 21(5):500-8. PubMed ID: 24142685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of free plasma homocysteine levels in patients hospitalized with acute coronary syndrome.
    van Oijen MG; Claessen BE; Clappers N; van Schaik A; Laheij RJ; Jansen JB; Peters WH; Verheugt FW
    Am J Cardiol; 2008 Jul; 102(2):135-9. PubMed ID: 18602509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study.
    Kristensen SL; Ahlehoff O; Lindhardsen J; Erichsen R; Lamberts M; Khalid U; Nielsen OH; Torp-Pedersen C; Gislason GH; Hansen PR
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):857-62. PubMed ID: 25316773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry.
    Lee SH; Ha JW; Kim JS; Choi EY; Park S; Kang SM; Choi D; Jang Y; Chung N
    Coron Artery Dis; 2009 Jan; 20(1):33-9. PubMed ID: 18997620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
    West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
    Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention.
    Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR
    Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
    Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
    Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.